Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

Impact of pharmacological agents on mitochondrial function: a growing opportunity?

Stoker ML, Newport E, Hulit JC, West AP, Morten KJ.

Biochem Soc Trans. 2019 Nov 7. pii: BST20190280. doi: 10.1042/BST20190280. [Epub ahead of print]

PMID:
31696924
2.

The influence of local market and household factors on aflatoxin presence in maize and symptoms of its exposure to children in Guatemala.

Voth-Gaeddert LE, Stoker M, Torres OR, Oerther DB.

Int J Environ Health Res. 2019 Mar 22:1-15. doi: 10.1080/09603123.2019.1594721. [Epub ahead of print]

PMID:
30897935
3.

Association of aflatoxin exposure and height-for-age among young children in Guatemala.

Voth-Gaeddert LE, Stoker M, Torres O, Oerther DB.

Int J Environ Health Res. 2018 Jun;28(3):280-292. doi: 10.1080/09603123.2018.1468424. Epub 2018 Apr 28.

PMID:
29706087
4.

What causes childhood stunting among children of San Vicente, Guatemala: Employing complimentary, system-analysis approaches.

Voth-Gaeddert LE, Stoker M, Cornell D, Oerther DB.

Int J Hyg Environ Health. 2018 Apr;221(3):391-399. doi: 10.1016/j.ijheh.2018.01.001. Epub 2018 Jan 5.

PMID:
29325698
5.

Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study.

Gálvez R, Navez ML, Moyle G, Maihöfner C, Stoker M, Ernault E, Nurmikko TJ, Attal N.

Clin J Pain. 2017 Oct;33(10):921-931. doi: 10.1097/AJP.0000000000000473.

PMID:
28872473
6.

Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.

van Nooten F, Treur M, Pantiri K, Stoker M, Charokopou M.

Clin Ther. 2017 Apr;39(4):787-803.e18. doi: 10.1016/j.clinthera.2017.02.010. Epub 2017 Mar 30. Review.

7.

Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.

Vinik AI, Perrot S, Vinik EJ, Pazdera L, Jacobs H, Stoker M, Long SK, Snijder RJ, van der Stoep M, Ortega E, Katz N.

BMC Neurol. 2016 Dec 6;16(1):251.

8.

Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.

Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ, Schregardus DS, Long SK, Lambourg B, Katz N.

J Pain. 2017 Jan;18(1):42-53. doi: 10.1016/j.jpain.2016.09.008. Epub 2016 Oct 13.

9.

The Ethics of a Postmortem Testicular Harvest.

Stoker M, Landry A.

J Emerg Med. 2016 Jan;50(1):178-80. doi: 10.1016/j.jemermed.2015.09.020. Epub 2015 Oct 26.

PMID:
26514307
10.

Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature.

Alleman CJ, Westerhout KY, Hensen M, Chambers C, Stoker M, Long S, van Nooten FE.

Diabetes Res Clin Pract. 2015 Aug;109(2):215-25. doi: 10.1016/j.diabres.2015.04.031. Epub 2015 May 6. Review.

11.

Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza).

Katz NP, Mou J, Paillard FC, Turnbull B, Trudeau J, Stoker M.

Clin J Pain. 2015 Oct;31(10):859-66. doi: 10.1097/AJP.0000000000000186.

PMID:
25503598
12.

Evidence-based fluid optimisation?

Stevenson S, Stoker M.

Anaesthesia. 2014 Jul;69(7):788-9. doi: 10.1111/anae.12742. No abstract available.

13.

Decreased Rate of CSF Leakage Associated with Complete Reconstruction of Suboccipital Cranial Defects.

Stoker MA, Forbes JA, Hanif R, Cooper C, Nian H, Konrad PE, Neimat JS.

J Neurol Surg B Skull Base. 2012 Aug;73(4):281-6. doi: 10.1055/s-0032-1312709.

14.

Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.

Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP.

Clin J Pain. 2014 Apr;30(4):286-94. doi: 10.1097/AJP.0b013e31829a4ced.

PMID:
23765045
15.

Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database.

Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP.

Pain. 2013 Sep;154(9):1632-9. doi: 10.1016/j.pain.2013.04.044. Epub 2013 May 21.

PMID:
23707278
16.

A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.

Martini CH, Yassen A, Krebs-Brown A, Passier P, Stoker M, Olofsen E, Dahan A.

Eur J Pain. 2013 Nov;17(10):1491-501. doi: 10.1002/j.1532-2149.2013.00329.x. Epub 2013 May 6.

PMID:
23650124
17.

Are treatment benefits in neuropathic pain reflected in the Self Assessment of Treatment questionnaire?

Wiklund I, Holmstrom S, Stoker M, Wyrwich KW, Devine M.

Health Qual Life Outcomes. 2013 Jan 18;11:8. doi: 10.1186/1477-7525-11-8.

18.

Validation of the Self-Assessment of Treatment Questionnaire among Patients with Postherpetic Neuralgia.

Wyrwich KW, Kawata AK, Thompson C, Holmstrom S, Stoker M, Wiklund I.

Pain Res Treat. 2012;2012:621619. doi: 10.1155/2012/621619. Epub 2012 Aug 13.

19.

Prior cholecystectomy as a predictor of preoperative vitamin D deficiency in adults undergoing spine surgery.

Stoker GE, Buchowski JM, Stoker ME.

Arch Surg. 2012 Jun;147(6):577-8. doi: 10.1001/archsurg.2012.463. No abstract available.

PMID:
22786550
20.

Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups.

Martini C, Yassen A, Olofsen E, Passier P, Stoker M, Dahan A.

J Pain Res. 2012;5:51-9. doi: 10.2147/JPR.S30406. Epub 2012 Mar 15.

Supplemental Content

Loading ...
Support Center